These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 20512194)
41. Reliability of X-rays and bone scans for the assessment of changes in skeletal metastases from breast cancer. Shackleton M; Yuen K; Little AF; Schlicht S; McLachlan SA Intern Med J; 2004 Nov; 34(11):615-20. PubMed ID: 15546455 [TBL] [Abstract][Full Text] [Related]
42. [The value of routine bone scintigraphy in primary operable breast cancer]. Thomsen HS; Munck O; Andersen KW Ugeskr Laeger; 1984 Jun; 146(26):1915-8. PubMed ID: 6506284 [No Abstract] [Full Text] [Related]
43. Bone and peritoneal metastasis of breast carcinoma: findings on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Ozcan Kara P; Kara T; Kara Gedik G; Sari O Rev Esp Med Nucl; 2011; 30(3):180-1. PubMed ID: 21334777 [No Abstract] [Full Text] [Related]
44. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
45. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer. Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451 [TBL] [Abstract][Full Text] [Related]
46. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219 [TBL] [Abstract][Full Text] [Related]
47. Breast cancer staging in a single session: whole-body PET/CT mammography. Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831 [TBL] [Abstract][Full Text] [Related]
48. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911 [TBL] [Abstract][Full Text] [Related]
49. MRI and PET/CT of patients with bone metastases from breast carcinoma. Grankvist J; Fisker R; Iyer V; Fründ ET; Simonsen C; Christensen T; Stenbygaard L; Ewertz M; Larsson EM Eur J Radiol; 2012 Jan; 81(1):e13-8. PubMed ID: 21227614 [TBL] [Abstract][Full Text] [Related]
50. [Evaluation and classification of drug therapy for breast cancer with bone-only metastasis]. Meng XY; Song ST Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):161-165. PubMed ID: 28316212 [TBL] [Abstract][Full Text] [Related]
51. Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast. Bellamy EA; Nicholas D; Ward M; Coombes RC; Powles TJ; Husband JE Clin Radiol; 1987 Jul; 38(4):351-5. PubMed ID: 3621814 [TBL] [Abstract][Full Text] [Related]
52. Usefulness of current techniques in detecting and monitoring bone metastases from breast cancer. Parbhoo SP J R Soc Med; 1985; 78 Suppl 9(Suppl 9):7-10. PubMed ID: 3876441 [No Abstract] [Full Text] [Related]
53. Assessment of therapy response in malignant tumours with 18F-fluorothymidine. Kumar R Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1334-8. PubMed ID: 17479261 [No Abstract] [Full Text] [Related]
54. [The role of computed tomography in benign tumors and tumor-like lesions of the bones]. Amiraslanov AT; Nadzhafov SR Khirurgiia (Mosk); 2012; (5):60-2. PubMed ID: 22810538 [TBL] [Abstract][Full Text] [Related]
55. Types of bone metastases in women with breast cancer undergoing systemic treatments. Vassiliou V; Kardamakis D; Quattrocchi CC; Dell'aia P; Beomonte Zobel B Radiol Med; 2008 Aug; 113(5):771-2; author reply 772-3. PubMed ID: 18629447 [No Abstract] [Full Text] [Related]
56. Detection of bone metastasis from breast cancer. An accurate, four-film, roentgenographic survey. Hait G; Hoerr SO; Hughes CR Cleve Clin Q; 1971 Jan; 38(1):1-4. PubMed ID: 5099189 [No Abstract] [Full Text] [Related]
57. Huge primary soft tissue sarcoma of the breast on bone scan. Shen YY; Wu YC; Kao CH; Hsieh TC Clin Nucl Med; 2014 Jan; 39(1):99-101. PubMed ID: 24152643 [TBL] [Abstract][Full Text] [Related]
58. [Utility of SPECT-CT in the characterization of rib injuries]. Giménez MA; de la Cueva L; Navarro P; Arroyo E; Liévano P; Gonzalez M; Baringo T; Abós D Rev Esp Med Nucl; 2009; 28(6):299-300. PubMed ID: 19995535 [No Abstract] [Full Text] [Related]
59. [42 year old woman with anterior thoracic mass]. Molina Villaverde R; López González JL; Martín Valadés I; Navarro Expósito F; Arroyo Yustos M; Alvarez de Mon Soto M Rev Clin Esp; 2006 Mar; 206(3):155-6. PubMed ID: 16597385 [No Abstract] [Full Text] [Related]
60. Dual-energy CT-scan quantification of recalcification in osteolyses of the vertebral body due to mammary carcinomas in the course of antineoplastic treatment. Crone-Münzebrock W; Carl UM Clin Exp Metastasis; 1990; 8(2):173-9. PubMed ID: 2317957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]